Drug Companies Should Be Held More Accountable for Their Human Rights Responsibilities 英文参考文献.docVIP
- 1、本文档共2页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Drug Companies Should Be Held More Accountable for Their Human Rights Responsibilities 英文参考文献
Editorial
DrugCompaniesShouldBeHeldMoreAccountablefor
TheirHumanRightsResponsibilities
ThePLoSMedicineEditors*
Almost ten years ago, activism and
public protest resulted in a landmark
victory for the access to medicines move-
ment, when 39 of the world’s leading
pharmaceutical companies dropped their
collectivelawsuitagainsttheSouthAfrican
governmentforattemptingtolegalizethe
importationofcheapergenericversionsof
drugs[1].Followingasettlement,medica-
tionprices—including thoseforantiretro-
virals to treat the millions of South
Africans with HIV/AIDS—dropped, and
public pressure on the pharmaceutical
industrywashailedasuccess[2].Adecade
later it’s time again for action—to hold
drug companies accountable for their
human rights responsibilities to make
medicinesavailableandaccessibletothose
inneed.
uponanextensiveandconsultativeprocess
with multiple stakeholders—include re-
sponsibilities for transparency, manage-
ment,monitoringandaccountability,pric-
ing, and ethical marketing. They identify
best practice as including access to med-
icines, differential pricing between and
within countries, commercial voluntary
licensingthatallowsfortheproductionof
cheapergenerics,investmentintoresearch
and development (RD) of neglected
diseases, and engagement in public–pri-
vate partnerships. The Guidelines also
recommend against lobbying for more
protection in intellectual property laws,
applying for patents for trivial modifica-
tions of existing medicines, inappropriate
drug promotion, and excessive pricing.
Indeed,amostnotableaspectoftheHunt
Report is its revelation that many of the
obstaclesStatesfaceindeliveringtheright
to health to their citizens are created by
theseverydrugcompanypractices[7].
ThechiefpropositionintheGuidelines
is that pharmaceutical companies, by
virtue of being granted by society the
monopoly and power to develop medi-
cines, hold that power (the patent) with
express conditions. And these conditions
include human rights responsibilities to
make
您可能关注的文档
- Down-Regulating Sphingolipid Synthesis Increases Yeast Lifespan 英文参考文献.doc
- Down-Regulation of NDRG1 Promotes Migration of Cancer Cells during Reoxygenation 英文参考文献.doc
- Down-Regulation of SerumGlucocorticoid Regulated Kinase 1 in Colorectal Tumours Is Largely Independent of Promoter Hypermethylation 英文参考文献.doc
- Down-Regulation of ZnT8 Expression in INS-1 Rat Pancreatic Beta Cells Reduces Insulin Content and Glucose-Inducible Insulin Secretion 英文参考文献.doc
- Down-Regulation of Replication Factor C-40 (RFC40) Causes Chromosomal Missegregation in Neonatal and Hypertrophic Adult Rat Cardiac Myocytes 英文参考文献.doc
- Down-Regulation of Small Rubber Particle Protein Expression Affects Integrity of Rubber Particles and Rubber Content in Taraxacum brevicorniculatum 英文参考文献.doc
- Down-Regulation of Neogenin Accelerated Glioma Progression through Promoter Methylation and Its Overexpression in SHG-44 Induced Apoptosis 英文参考文献.doc
- Down-Regulation of Yes Associated Protein 1 Expression Reduces Cell Proliferation and Clonogenicity of Pancreatic Cancer Cells 英文参考文献.doc
- Downgrading MELD Improves the Outcomes after Liver Transplantation in Patients with Acute-on-Chronic Hepatitis B Liver Failure 英文参考文献.doc
- Downregulation of Genes Involved in Metabolism and Oxidative Stress in the Peripheral Leukocytes of Huntington's Disease Patients 英文参考文献.doc
文档评论(0)